In a bondholder regulatory document, the hospital disclosed its net revenue was down 26 percent or $8.1 million from Oct. 1 to Oct. 20, compared to the hospital’s average net revenue figures over the previous nine months. THP also disclosed its emergency department visits fell by 53 percent during the first 20 days of October, and the hospital’s average daily occupancy fell by 91 patients during the same period, according to the report.
It is likely lingering fears of contracting Ebola has caused patients to avoid THP, as two nurses who came into contact with Mr. Duncan later tested positive for the virus.
John Bertrand, MD, an obstetrician at THP, said the Ebola scare has affected his practice, with 15 of his patients recently deciding to give birth at other facilities, according to the report.
With patients cancelling appointments and avoiding the hospital, Moody’s Investors Service revised the outlook for Arlington-based Texas Health Resources — THP’s parent company — last week. Its outlook was changed to “developing” from “positive” due to the analysts attempting to determine the impact the Ebola scare would have on patient volumes.
More articles on Ebola:
Physicians already disapprove of Obama’s new ‘Ebola czar’
Nebraska Medical Center to release patient treated for Ebola
Flu? Ebola? Sorting out viral cases during Ebola scare could strain ED capacity
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
